Rekombinanter HLA-DRA Antikörper
Kurzübersicht für Rekombinanter HLA-DRA Antikörper (ABIN7826065)
Target
Alle HLA-DRA Antikörper anzeigenAntikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Güteklasse
Klon
-
-
Expressionssystem
- CHO Cells
-
Verwendungszweck
- HLA-DR recombinant monoclonal antibody, clone L243 targeting human HLA-DR recombinant protein.
-
Kreuzreaktivität
- Human
-
Produktmerkmale
- In Vivo Functional Grade Antibodies are optimized for mouse and rat studies, ensuring safety and accuracy in live animal experiments. Each antibody is highly purified and validated by flow cytometry using positive and negative control cell lines. The collection includes mouse-target and human-target antibodies suitable for syngeneic and xenograft tumor models, supporting robust preclinical immunotherapy research
-
Aufreinigung
- Protein A purified
-
Reinheit
- > 95 % by SDS-PAGE under reducing conditions.
-
Sterilität
- 0.2 μm filtered
-
Endotoxin-Niveau
- < 1 EU per 1 mg of the protein by the LAL method.
-
Immunogen
- Human HLA-DR recombinant protein
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- ≥ 3 μg/μL
-
Buffer
- PBS pH 7.4 with no stabilizers or preservatives added
-
Konservierungsmittel
- Without preservative
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot to avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- HLA-DRA (HLA Class II DR alpha (HLA-DRA))
-
Andere Bezeichnung
- HLA-DRA
-
Hintergrund
-
Gene description: major histocompatibility complex, class II, DR alpha
Gene alias: HLA-DRA1
-
Gen-ID
- 3122
-
Pathways
- T-Zell Rezeptor Signalweg, CXCR4-mediated Signaling Events, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-